![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Active Filter(s):
Details:
Through the acquisition, Carlin expand its portfolio of OTC brands by including Penetrex, a unique formulation, using natural ingredients like Arnica, Vitamin B6 and Methylsulfonylmethane, used to treat joint and muscle pain.
Lead Product(s): Arnica Montana,Pyridoxine Hydrochloride,Dimethyl Sulfone
Therapeutic Area: Rheumatology Product Name: Penetrex
Highest Development Status: Approved Product Type: Large molecule
Partner/Sponsor/Collaborator: Carlin Consumer Health
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 30, 2024